InMode designs, develops, manufactures and markets minimally-invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radio frequency technologies. These technologies are used to remodel subdermal adipose, or fatty, tissue in a variety of procedures including liposuction with simultaneous skin tightening, body and face contouring and ablative skin rejuvenation treatments. In addition to the minimally-invasive technologies, Co. designs, develops, manufactures and markets non-invasive medical aesthetic products that target an array of procedures including permanent hair reduction, wrinkle reduction and cellulite treatment.
INMD SEC Filing Email Alerts Service
INMD SEC Filing Email Alerts Service
|
Free INMD Email Alerts: Get SEC Filing Alerts Get Dividend Alerts |
Buy (3.00 out of 4) 28th percentile
(ranked lower than approx. 72% of all stocks covered)
Analysts' Target Price: INMD Stock Forecast Based on Zacks ABR data; powered by Xignite |